Total Payments
$386.29
2024 Payments
$65.57
Companies
10
Transactions
24
Medicare Patients
1,430
Medicare Billing
$187,623
Payment Breakdown by Category
Food & Beverage$386.29 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $386.29 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $88.09 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $85.46 | 6 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.39 | 3 | $0 (2024) |
| Olympus America Inc. | $45.71 | 1 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $29.48 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.80 | 2 | $0 (2022) |
| QOL Medical, LLC | $16.92 | 1 | $0 (2023) |
| Ardelyx, Inc. | $15.00 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $14.18 | 1 | $0 (2024) |
| ABBVIE INC. | $12.26 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.57 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($51.39) |
| 2023 | $64.85 | 4 | Celgene Corporation ($32.14) |
| 2022 | $210.16 | 15 | Janssen Biotech, Inc. ($85.46) |
| 2021 | $45.71 | 1 | Olympus America Inc. ($45.71) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 05/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/03/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Neuroscience | ||||||
| 01/20/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Neuroscience | ||||||
| 01/10/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Neuroscience | ||||||
| 11/18/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Immunology | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Gastroenterology | ||||||
| 10/14/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $13.69 | General |
| 08/19/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: Neuroscience | ||||||
| 08/12/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Immunology | ||||||
| 08/05/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 07/25/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 07/08/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.84 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Neuroscience | ||||||
| 05/20/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Immunology | ||||||
| 04/15/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 04/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Gastroenterology | ||||||
| 09/28/2021 | Olympus America Inc. | HANAROSTENT LowAxTM Colon/Rectum(NNN) (Device) | Food and Beverage | In-kind items and services | $45.71 | General |
| Category: Endotherapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 330 | 477 | $180,854 | $38,781 |
| 2022 | 14 | 776 | 1,087 | $518,316 | $101,702 |
| 2021 | 6 | 324 | 445 | $224,307 | $47,140 |
Total Patients
1,430
Total Services
2,009
Medicare Billing
$187,623
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 135 | 269 | $61,870 | $18,230 | 29.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 132 | 140 | $61,320 | $15,364 | 25.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $30,305 | $1,892 | 6.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $21,780 | $1,610 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $3,595 | $990.40 | 27.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 16 | $1,984 | $693.60 | 35.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 266 | 536 | $123,280 | $32,451 | 26.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 173 | 186 | $107,212 | $31,641 | 29.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 98 | 107 | $46,866 | $12,221 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 42 | 43 | $68,585 | $3,509 | 5.1% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 16 | $27,720 | $2,805 | 10.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 14 | 14 | $26,565 | $2,794 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 27 | $9,423 | $2,783 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 35 | $8,225 | $2,664 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $32,670 | $2,235 | 6.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,040 | $2,163 | 30.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $27,830 | $2,095 | 7.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $23,716 | $2,018 | 8.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 40 | $4,960 | $1,316 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $4,224 | $1,008 | 23.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 128 | 140 | $70,000 | $24,371 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 127 | 234 | $53,820 | $14,616 | 27.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 27 | 28 | $44,660 | $2,450 | 5.5% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 14 | 14 | $23,716 | $2,218 | 9.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 15 | 15 | $27,225 | $1,850 | 6.8% |
About Dr. Grace Yang, M.D
Dr. Grace Yang, M.D is a Gastroenterology healthcare provider based in Secaucus, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1083000962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grace Yang, M.D has received a total of $386.29 in payments from pharmaceutical and medical device companies, with $65.57 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($386.29).
As a Medicare-enrolled provider, Yang has provided services to 1,430 Medicare beneficiaries, totaling 2,009 services with total Medicare billing of $187,623. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Secaucus, NJ
- Active Since 04/08/2015
- Last Updated 11/07/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083000962
Products in Payments
- ZEPOSIA (Drug) $88.09
- STELARA (Biological) $85.46
- ENTYVIO (Biological) $51.39
- HANAROSTENT LowAxTM Colon/Rectum(NNN) (Device) $45.71
- Sucraid (Drug) $16.92
- REBYOTA (Biological) $15.79
- IBSRELA (Drug) $15.00
- TRULANCE (Drug) $14.42
- XIFAXAN (Drug) $13.38
- RINVOQ (Biological) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.